Publications by authors named "NingJing Lin"

Claim this Profile
P
Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial.
Yanyan Liu, Ningjing Lin, Shuhua Yi, Huiqiang Huang, Ye Guo, Liling Zhang

Int J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial.
Ningjing Lin, Xiuhua Sun, Hui Zhou, Liqun Zou, Keshu Zhou, Liling Zhang

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial.
Suisui Kan, Hai Bai, Hui Liu, Jie Cui, Xiaoyan Ke, Ningjing Lin

Leuk Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of standard BEACOPP regimen versus ABVD regimen for treatment of advanced Hodgkin's lymphoma.
Ningjing Lin, Chuan He, Qingyuan Zhang, Xiaonan Hong, Lihong Liu

J Cancer Res Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multifunctional Nanocatalytic Metal-Organic Framework as a Ferroptosis Amplifier for Mild Hyperthermia Photothermal Therapy.
Ying Deng, Duo Wang, Wenhua Zhao, Guanhua Qiu, Xiaoqi Zhu, Ningjing Lin

Research (Wash D C)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
Fei Qi, Yuce Wei, Meng Wu, Yan Sun, Yan Xie, Ningjing Lin

Ann Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
Yanfei Liu, Lingyan Ping, Yuqin Song, Yongjing Tang, Wen Zheng, Ningjing Lin

BMC Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma.
Weiping Liu, Ningjing Lin, Xinqin Feng, Yan Xie, Chong You

Signal Transduct Target Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Ubiquitination and Phosphorylation Epigenetics Reshaping by MG132-Loaded Fe-MOF Disarms Treatment Resistance to Repulse Metastatic Colorectal Cancer.
Zhaoting Bu, Jianjun Yang, Yan Zhang, Tao Luo, Chao Fang, Ningjing Lin

Adv Sci (Weinh)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra-nodal NKT cell lymphoma: A multicenter real-world study in China.
Honghao Gao, Ningjing Lin, Zhenyang Gu, Shihua Zhao, Xiaopei Wang

Eur J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.
Zhitao Ying, Yan Xie, Wen Zheng, Weiping Liu, Ningjing Lin, Lingyan Ping

Bone Marrow Transplant· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Xiao-Peng Tian, Yu-Chen Zhang, Ning-Jing Lin, Liang Wang, Zhi-Hua Li, Tong-Yu Lin

Cell Rep Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation.
Fei Qi, Wenyuan Zhou, Yan Xie, Yan Sun, Meng Wu, Ningjing Lin

Aging (Albany NY)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study.
Ningjing Lin, Mingzhi Zhang, Hai Bai, Hui Liu, Jie Cui

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Phase II Study of Pegaspargase-COEP Plus Radiotherapy in Patients With Newly Diagnosed Extra-Nodal NK/T-Cell Lymphoma.
Shaoxuan Hu, Ningjing Lin, Jiaxin Liu, Yan Sun, Weiping Liu

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma.
Zhitao Ying, Ting He, Shanzhao Jin, Xiaopei Wang, Wen Zheng, Ningjing Lin, Lingyan Ping

Chin J Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.
Xiao-Sheng Ding, Lan Mi, Yu-Qin Song, Wei-Ping Liu, Hui Yu, Ning-Jing Lin

World J Clin Cases· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.
Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Lingyan Ping

BMC Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group.
Weiping Liu, Yong Yang, Shunan Qi, Ying Wang, Xia He, Liling Zhang, Baolin Qu, Ningjing Lin

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies.
Chaoting Zhang, Heyilimu Palashati, Zhuona Rong, Ningjing Lin, Luyan Shen

Mol Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
Weiping Liu, Xinqiang Ji, Yuqin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Lingyan Ping

Cancer Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives.
Ningjing Lin, Yuqin Song, Jun Zhu

Chin J Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.
Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Lingyan Ping

Mol Ther Oncolytics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A safe and potent anti-CD19 CAR T cell therapy.
Zhitao Ying, Xue F Huang, Xiaoyu Xiang, Yanling Liu, Xi Kang, Yufu Lin, Ningjing Lin, Lingyan Ping, Songfeng Lin, Lindsey Jones

Nat Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation.
Zhitao Ying, Lan Mi, Nina Zhou, Xuejuan Wang, Zhi Yang, Ningjing Lin, Lingyan Ping

Chin J Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis